| BRXVX | VTISX | BRXVX / VTISX | |
| Total Expense Ratio | 0.43 | 0.05 | 915% |
| Annual Report Gross Expense Ratio | 0.44 | 0.05 | 936% |
| Fund Existence | 10 years | 10 years | - |
| Gain YTD | 34.544 | 28.929 | 119% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.43B | 558B | 0% |
| Annual Yield % from dividends | 2.53 | 2.74 | 93% |
| Returns for 1 year | 33.82 | 28.01 | 121% |
| Returns for 3 years | 69.50 | 49.19 | 141% |
| Returns for 5 years | 58.58 | 32.70 | 179% |
| Returns for 10 years | 109.41 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SSEAX | 12.32 | 0.03 | +0.24% |
| SEI Screened World Equity Ex-US A (SIIT) | |||
| SUSYX | 13.32 | N/A | N/A |
| SEI US Managed Volatility Y (SIMT) | |||
| SXPRX | 54.76 | -0.02 | -0.04% |
| DWS S&P 500 Index R6 | |||
| FLIAX | 9.84 | -0.01 | -0.10% |
| First Sentier American Listed Infras I | |||
| JFNSX | 77.09 | -0.19 | -0.25% |
| Janus Henderson Global Life Sciences S | |||